Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022		Mar. 31, 2021
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows
Cash and cash equivalents	$ 1,500,203	[1]	$ 193,852
Restricted cash included in deferred expenses and other assets, net	51,047		54,029
Total cash and cash equivalents and restricted cash	1,551,250		247,881
Supplemental disclosure of non-cash investing and financing activity:
Fundings and (repayments) of loan receivables and loan participations, net			(42,501)
Accounts payable for capital expenditures on real estate assets	2,053
Marketable securities transferred in connection with the defeasance of mortgage notes payable	252,571
Defeasance of mortgage notes payable	230,452
Accrued repurchase of stock			$ 1,802
Distributions to noncontrolling interests	34,467
Assumption of mortgage by third party	$ 62,825

[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).